Syringaresinol activates the skeletal muscle SIRT1–FNDC5/irisin axis to enhance weight management

Shuning Liu, Fang Zhao, Samuhaer Azhati, Wei Shan, Biaoxu Tao, Wen Zhong, Yan Wei, Wei Jiang, Kai Zhao, Chang Liu

Open source

DOI
10.1007/s13205-026-05027-z
Published
2026-09-12
Container
3 Biotech
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13205-026-05027-z,
  title = {Syringaresinol activates the skeletal muscle SIRT1–FNDC5/irisin axis to enhance weight management},
  author = {Shuning Liu and Fang Zhao and Samuhaer Azhati and Wei Shan and Biaoxu Tao and Wen Zhong and Yan Wei and Wei Jiang and Kai Zhao and Chang Liu},
  year = {2026},
  journal = {3 Biotech},
  doi = {10.1007/s13205-026-05027-z},
  url = {https://doi.org/10.1007/s13205-026-05027-z}
}

RIS

TY  - JOUR
TI  - Syringaresinol activates the skeletal muscle SIRT1–FNDC5/irisin axis to enhance weight management
AU  - Shuning Liu
AU  - Fang Zhao
AU  - Samuhaer Azhati
AU  - Wei Shan
AU  - Biaoxu Tao
AU  - Wen Zhong
AU  - Yan Wei
AU  - Wei Jiang
AU  - Kai Zhao
AU  - Chang Liu
PY  - 2026
JO  - 3 Biotech
DO  - 10.1007/s13205-026-05027-z
UR  - https://doi.org/10.1007/s13205-026-05027-z
ER  - 

APA

Liu, S., Zhao, F., Azhati, S., Shan, W., Tao, B., Zhong, W., Wei, Y., Jiang, W., Zhao, K., & Liu, C. (2026). Syringaresinol activates the skeletal muscle SIRT1–FNDC5/irisin axis to enhance weight management. 3 Biotech. https://doi.org/10.1007/s13205-026-05027-z

Source records